NCT02571062View on ClinicalTrials.gov

Bioequivalence Study - Reference Clinical Fexinidazole Tablet Versus Proposed Market Formulation

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Trypanosomiasis, African
Interventions
DRUG

Fexinidazole

Trial Locations (1)

Unknown

Biotrial, Rennes

All Listed Sponsors
lead

Drugs for Neglected Diseases

OTHER

NCT02571062 - Bioequivalence Study - Reference Clinical Fexinidazole Tablet Versus Proposed Market Formulation | Biotech Hunter | Biotech Hunter